308 related articles for article (PubMed ID: 30206203)
21. p53-mediated apoptosis is attenuated in Werner syndrome cells.
Spillare EA; Robles AI; Wang XW; Shen JC; Yu CE; Schellenberg GD; Harris CC
Genes Dev; 1999 Jun; 13(11):1355-60. PubMed ID: 10364153
[TBL] [Abstract][Full Text] [Related]
22. Reprogramming Methods Do Not Affect Gene Expression Profile of Human Induced Pluripotent Stem Cells.
Trevisan M; Desole G; Costanzi G; Lavezzo E; Palù G; Barzon L
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117672
[TBL] [Abstract][Full Text] [Related]
23. Inducing goat pluripotent stem cells with four transcription factor mRNAs that activate endogenous promoters.
Chen H; Zuo Q; Wang Y; Song J; Yang H; Zhang Y; Li B
BMC Biotechnol; 2017 Feb; 17(1):11. PubMed ID: 28193206
[TBL] [Abstract][Full Text] [Related]
24. Nonfunctional mutant Wrn protein leads to neurological deficits, neuronal stress, microglial alteration, and immune imbalance in a mouse model of Werner syndrome.
Hui CW; St-Pierre MK; Detuncq J; Aumailley L; Dubois MJ; Couture V; Skuk D; Marette A; Tremblay JP; Lebel M; Tremblay MÈ
Brain Behav Immun; 2018 Oct; 73():450-469. PubMed ID: 29908963
[TBL] [Abstract][Full Text] [Related]
25. The identification of a novel mutation (p.I223fs) in WRN associated with Werner syndrome.
Wu J; Pan S; Lin W; Wen J; Lu R; Chen G
Endocrine; 2024 Apr; 84(1):92-96. PubMed ID: 37856055
[TBL] [Abstract][Full Text] [Related]
26. A novel splice-site mutation of WRN (c.IVS28+2T>C) identified in a consanguineous family with Werner Syndrome.
Wu PF; Jin JY; Li JJ; He JQ; Fan LL; Jin M; Huang H; Xia K; Tang JY; Xiang R
Mol Med Rep; 2017 Jun; 15(6):3735-3738. PubMed ID: 28440507
[TBL] [Abstract][Full Text] [Related]
27. Telomerase protects werner syndrome lineage-specific stem cells from premature aging.
Cheung HH; Liu X; Canterel-Thouennon L; Li L; Edmonson C; Rennert OM
Stem Cell Reports; 2014 Apr; 2(4):534-46. PubMed ID: 24749076
[TBL] [Abstract][Full Text] [Related]
28. Werner's syndrome lymphoblastoid cells are hypersensitive to topoisomerase II inhibitors in the G2 phase of the cell cycle.
Pichierri P; Franchitto A; Mosesso P; Proietti de Santis L; Balajee AS; Palitti F
Mutat Res; 2000 Mar; 459(2):123-33. PubMed ID: 10725663
[TBL] [Abstract][Full Text] [Related]
29. Aging stem cells. A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging.
Zhang W; Li J; Suzuki K; Qu J; Wang P; Zhou J; Liu X; Ren R; Xu X; Ocampo A; Yuan T; Yang J; Li Y; Shi L; Guan D; Pan H; Duan S; Ding Z; Li M; Yi F; Bai R; Wang Y; Chen C; Yang F; Li X; Wang Z; Aizawa E; Goebl A; Soligalla RD; Reddy P; Esteban CR; Tang F; Liu GH; Belmonte JC
Science; 2015 Jun; 348(6239):1160-3. PubMed ID: 25931448
[TBL] [Abstract][Full Text] [Related]
30. Mismatch repair in extracts of Werner syndrome cell lines.
Bennett SE; Umar A; Oshima J; Monnat RJ; Kunkel TA
Cancer Res; 1997 Jul; 57(14):2956-60. PubMed ID: 9230208
[TBL] [Abstract][Full Text] [Related]
31. Werner syndrome and mutations of the WRN and LMNA genes in France.
Uhrhammer NA; Lafarge L; Dos Santos L; Domaszewska A; Lange M; Yang Y; Aractingi S; Bessis D; Bignon YJ
Hum Mutat; 2006 Jul; 27(7):718-9. PubMed ID: 16786514
[TBL] [Abstract][Full Text] [Related]
32. A deletion within the murine Werner syndrome helicase induces sensitivity to inhibitors of topoisomerase and loss of cellular proliferative capacity.
Lebel M; Leder P
Proc Natl Acad Sci U S A; 1998 Oct; 95(22):13097-102. PubMed ID: 9789047
[TBL] [Abstract][Full Text] [Related]
33. Functional role of the Werner syndrome RecQ helicase in human fibroblasts.
Dhillon KK; Sidorova J; Saintigny Y; Poot M; Gollahon K; Rabinovitch PS; Monnat RJ
Aging Cell; 2007 Feb; 6(1):53-61. PubMed ID: 17266675
[TBL] [Abstract][Full Text] [Related]
34. Role for the Werner syndrome protein in the promotion of tumor cell growth.
Opresko PL; Calvo JP; von Kobbe C
Mech Ageing Dev; 2007; 128(7-8):423-36. PubMed ID: 17624410
[TBL] [Abstract][Full Text] [Related]
35. Werner protein stimulates topoisomerase I DNA relaxation activity.
Laine JP; Opresko PL; Indig FE; Harrigan JA; von Kobbe C; Bohr VA
Cancer Res; 2003 Nov; 63(21):7136-46. PubMed ID: 14612507
[TBL] [Abstract][Full Text] [Related]
36. Metabolome Profiling of Partial and Fully Reprogrammed Induced Pluripotent Stem Cells.
Park SJ; Lee SA; Prasain N; Bae D; Kang H; Ha T; Kim JS; Hong KS; Mantel C; Moon SH; Broxmeyer HE; Lee MR
Stem Cells Dev; 2017 May; 26(10):734-742. PubMed ID: 28346802
[TBL] [Abstract][Full Text] [Related]
37. A model for the phenotypic presentation of Werner's syndrome.
Ostler EL; Wallis CV; Sheerin AN; Faragher RG
Exp Gerontol; 2002; 37(2-3):285-92. PubMed ID: 11772514
[TBL] [Abstract][Full Text] [Related]
38. Telomere instability in a human tumor cell line expressing a dominant-negative WRN protein.
Bai Y; Murnane JP
Hum Genet; 2003 Sep; 113(4):337-47. PubMed ID: 12827497
[TBL] [Abstract][Full Text] [Related]
39. The clinical characteristics of Werner syndrome: molecular and biochemical diagnosis.
Muftuoglu M; Oshima J; von Kobbe C; Cheng WH; Leistritz DF; Bohr VA
Hum Genet; 2008 Nov; 124(4):369-77. PubMed ID: 18810497
[TBL] [Abstract][Full Text] [Related]
40. WRN protein as a novel erythroblast immunohistochemical marker with applications for the diagnosis of Werner syndrome.
Sadahira Y; Sugihara T; Fujiwara H; Nishimura H; Suetsugu Y; Takeshita M; Okamura S; Goto M
Virchows Arch; 2015 Mar; 466(3):343-50. PubMed ID: 25503078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
